Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Change in Intangibles (2019 - 2025)

Ptc Therapeutics has reported Change in Intangibles over the past 7 years, most recently at $34.9 million for Q4 2025.

  • Quarterly results put Change in Intangibles at $34.9 million for Q4 2025, up 1179.01% from a year ago — trailing twelve months through Dec 2025 was $291.2 million (up 329.76% YoY), and the annual figure for FY2025 was $291.2 million, up 329.76%.
  • Change in Intangibles for Q4 2025 was $34.9 million at Ptc Therapeutics, down from $252.8 million in the prior quarter.
  • Over the last five years, Change in Intangibles for PTCT hit a ceiling of $252.8 million in Q3 2025 and a floor of $808000.0 in Q1 2025.
  • Median Change in Intangibles over the past 5 years was $18.4 million (2022), compared with a mean of $33.1 million.
  • Peak annual rise in Change in Intangibles hit 2364.89% in 2025, while the deepest fall reached 98.52% in 2025.
  • Ptc Therapeutics' Change in Intangibles stood at $15.3 million in 2021, then rose by 20.0% to $18.4 million in 2022, then increased by 24.6% to $22.9 million in 2023, then crashed by 88.08% to $2.7 million in 2024, then skyrocketed by 1179.01% to $34.9 million in 2025.
  • The last three reported values for Change in Intangibles were $34.9 million (Q4 2025), $252.8 million (Q3 2025), and $2.7 million (Q2 2025) per Business Quant data.